Malhotra, R., Devries, D. K., Luchs, J., Kabat, A., Schechter, B. A., Shen Lee, B., . . . Karpecki, P. (2019). Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies. Cornea.
Styl ChicagoMalhotra, Ranjan, et al. "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, On Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies." Cornea 2019.
Citace podle MLAMalhotra, Ranjan, et al. "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, On Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies." Cornea 2019.